Back to Journals » OncoTargets and Therapy » Volume 16

Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report

Total article views   HTML views PDF downloads Totals
3,895 Dovepress* 2,991+ 76 3,067
PubMed Central* 904 217 1,121
Totals 3,895 293 4,188
*Since 21 February 2023
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 2 3

View citations on PubMed Central and Google Scholar